Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4126
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $218K | ﹤0.01% |
4,400
-33,208
| -88% | -$1.54M |
|
|
FSP
4127
Franklin Street Properties
FSP
$45.8M
| $217K | ﹤0.01% |
132,195
+33,946
| +35% | +$56.6K |
|
4128
Instil Bio
TIL
$50.8M
| $217K | ﹤0.01% |
10,400
-4,426
| -30% | -$92.5K |
|
4129
Advantage Solutions
ADV
$387M
| $216K | ﹤0.01% |
6,539
+1,475
| +29% | +$48.6K |
|
|
CD
4130
Chaince Digital Holdings
CD
$244M
| $216K | ﹤0.01% |
+56,032
| New | +$282K |
|
4131
Inhibikase Therapeutics
IKT
$385M
| $215K | ﹤0.01% |
110,252
+26,252
| +31% | +$51.4K |
|
4132
MoonLake Immunotherapeutics
MLTX
$1.41B
| $215K | ﹤0.01% |
4,553
-15,046
| -77% | -$613K |
|
4133
HF Foods Group
HFFG
$95.9M
| $215K | ﹤0.01% |
67,483
+24,198
| +56% | +$92.2K |
|
|
STRS
4134
DELISTED
STRATUS PPTYS INC
STRS
| $214K | ﹤0.01% |
11,359
+5,732
| +102% | +$105K |
|
4135
CF Bankshares
CFBK
$231M
| $213K | ﹤0.01% |
8,905
+8,478
| +1,985% | +$194K |
|
4136
FT Vest US Equity Deep Buffer ETF August
DAUG
$374M
| $213K | ﹤0.01% |
5,120
-10
| -0.2% | -$395 |
|
4137
iShares S&P 100 ETF
OEF
$20.4B
| $213K | ﹤0.01% |
700
| – | – |
|
4138
Lakeland Industries
LAKE
$120M
| $213K | ﹤0.01% |
15,629
+11,638
| +292% | +$195K |
|
|
STLN
4139
Starling Oncology, Inc. Common Stock
STLN
$632M
| $213K | ﹤0.01% |
+103,670
| New | +$259K |
|
4140
BARK
BARK
$96.8M
| $212K | ﹤0.01% |
12,039
+3,038
| +34% | +$69.8K |
|
4141
Acacia Research
ACTG
$451M
| $211K | ﹤0.01% |
58,987
+21,915
| +59% | +$75.5K |
|
4142
Gran Tierra Energy
GTE
$337M
| $211K | ﹤0.01% |
44,260
+1,567
| +4% | +$7.43K |
|
4143
CALL
Academy Sports + Outdoors
ASO
$3.07B
| $211K | ﹤0.01% |
+4,700
| New | +$195K |
|
|
AISP
4144
Airship AI Holdings
AISP
$69.6M
| $210K | ﹤0.01% |
35,643
+26,907
| +308% | +$120K |
|
4145
CALL
Illumina
ILMN
$29.1B
| $210K | ﹤0.01% |
2,200
| – | – |
|
4146
Karooooo
KARO
$1.93B
| $210K | ﹤0.01% |
4,282
-4,278
| -50% | -$202K |
|
|
RPT
4147
Rithm Property Trust
RPT
$98.2M
| $210K | ﹤0.01% |
12,946
+9,674
| +296% | +$157K |
|
4148
iShares MSCI Switzerland ETF
EWL
$2.23B
| $210K | ﹤0.01% |
3,824
-9,700
| -72% | -$518K |
|
4149
FT Vest US Equity Enhance & Moderate Buffer ETF January
XJAN
$41.9M
| $210K | ﹤0.01% |
6,001
+1,605
| +37% | +$53.7K |
|
4150
ROBO Global Robotics & Automation Index ETF
ROBO
$2.1B
| $209K | ﹤0.01% |
3,500
-1,112
| -24% | -$59.5K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.